SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-11-052492
Filing Date
2011-10-11
Accepted
2011-10-11 17:47:36
Documents
1
Period of Report
2011-10-06

Document Format Files

Seq Description Document Type Size
1 AUERBACH F4 rrd323489.html 4  
1 AUERBACH F4 rrd323489.xml 4 3415
  Complete submission text file 0001181431-11-052492.txt   4876
Mailing Address 10940 WILSHIRE BLVD. SUITE 600 LOS ANGELES CA 90024
Business Address
AUERBACH ALAN H (Reporting) CIK: 0001358285 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-52811 | Film No.: 111136229

Mailing Address 10940 WILSHIRE BLVD. SUITE 600 LOS ANGELES CA 90024
Business Address 10940 WILSHIRE BLVD. SUITE 600 LOS ANGELES CA 90024 (310) 443-4150
PUMA BIOTECHNOLOGY, INC. (Issuer) CIK: 0001401667 (see all company filings)

IRS No.: 770683487 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 6770 Blank Checks